Treatment Combination Used Most for Mesothelioma
Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is being used by doctors to treat malignant peritoneal mesothelioma (MPM) more often. This is the finding of a study published in the Annals of Surgical Oncology. This is promising news because research has shown the CRS-HIPEC can be an effective treatment for patients with MPM. Mesothelioma Caused by Asbestos Exposure MPM is caused by exposure to a toxic material called asbestos. Most doctors believe it is caused from ingestion of asbestos fibers and that microscopic asbestos fibers become embedded in the abdomen. After about 20-50 years, these fibers can cause inflammation and mutations that ultimately caused tumors to form. This cancer occurs in less than 1,000 people in the United States … Continue reading Treatment Combination Used Most for Mesothelioma
Long Term Survival Possible with CRS/HIPEC for Mesothelioma
There’s hopeful news for peritoneal mesothelioma patients facing the prospect of surgery. A new study on the benefits of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) finds that both the process and outcomes have improved over time. Cytoreductive surgery refers to any surgery aimed at removing as much cancerous tissue as possible. With peritoneal cancers such as mesothelioma, the surgeons may follow the procedure with a wash of heated chemotherapy drugs into the open body cavity. The goal of HIPEC is to destroy any remaining mesothelioma cells and to help keep new mesothelioma cells from growing. A study of 1,000 cytoreductive surgery/HIPEC patients, 72 of whom had mesothelioma, found that complications have decreased and survival has increased for all of … Continue reading Long Term Survival Possible with CRS/HIPEC for Mesothelioma
Get your free copy of
“Surviving Mesothelioma” Today!